Brief: Perspective Therapeutics Q1 EPS USD -0.25
11/05/2026 21:07
May 11 (Reuters) - Perspective Therapeutics Q1 net income USD -26.189 million. Q1 operating income USD -28.281 million Q1 grant revenue USD 76 thousand
Recent news on Perspective Therapeutics
See all newsBrief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise
U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson
Brief: Perspective Therapeutics FY EPS USD -1.4